Actively Recruiting
Warfarin Patient Self-management Implementation in the US Healthcare System
Led by University of Utah · Updated on 2024-05-08
150
Participants Needed
4
Research Sites
111 weeks
Total Duration
On this page
Sponsors
U
University of Utah
Lead Sponsor
B
Brigham and Women's Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
In the US, patients receiving warfarin therapy are rarely allowed to engage in patient self-management (PSM) which is less burdensome, less expensive, and safer than standard clinic-directed warfarin management. The long-term objective of our application is to improve the safety of ambulatory warfarin therapy through increasing the implementation of PSM.
CONDITIONS
Official Title
Warfarin Patient Self-management Implementation in the US Healthcare System
Who Can Participate
Eligibility Criteria
You may qualify if you...
- At least 18 years of age treated with warfarin for any indication for at least 9 months prior to enrollment
- Willing and able to test their own INR using a home INR monitoring device or have same-day access to clinic INR results
- Willing to make independent decisions about warfarin dosing based on INR results
- Able to perform INR tests at least every 2 weeks
- Currently have and willing to maintain internet access for the duration of the study to complete online data forms
- Have an anticipated duration of warfarin therapy of at least 6 months
You will not qualify if you...
- Goal INR range other than 2.0-3.0 or 2.5-3.5
- Known poor adherence to warfarin therapy
- Non-English speaking
- Inability or refusal to provide written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
VA Loma Linda Healthcare System
Loma Linda, California, United States, 92357
Actively Recruiting
2
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
Completed
3
University of Michigan
Ann Arbor, Michigan, United States, 48109
Completed
4
University of Utah Thrombosis Center
Salt Lake City, Utah, United States, 84112
Actively Recruiting
Research Team
D
Daniel M Witt, PharmD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here